PAJOUHESH HASSAN has a total of 13 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NEUROPORE THERAPIES INC, CHAUVIN BLACHE LAB and BUCHMANN BERND.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Pajouhesh Hassan | 13 |
#2 | Ding Yanbing | 6 |
#3 | Pajouhesh Hossein | 6 |
#4 | Holland Richard | 5 |
#5 | Kaul Ramesh | 5 |
#6 | Zhou Yuanxi | 4 |
#7 | Grimwood Mike | 4 |
#8 | Zhang Lingyun | 3 |
#9 | Zhu Yongbao | 3 |
#10 | Tan Jason | 3 |
Publication | Filing date | Title |
---|---|---|
WO2015127549A1 | Heterocyclic inhibitors of the sodium channel | |
US2012220564A1 | Selective calcium channel modulators | |
US2012220605A1 | Oxopiperazine derivatives for the treatment of pain and epilepsy | |
US2009298834A1 | 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers | |
US2008227823A1 | Amide derivatives as calcium channel blockers | |
US2009221603A1 | Heterocyclic amide derivatives as calcium channel blockers |